{"entity":{"type":"insider","cik":"0001707648","url":"/insider/0001707648","json_url":"/insider/0001707648.json","name":"TOMBESI PAOLO","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2020-03-26","last":"2022-07-29","span_basis":"filed_date"},"name_variants":[{"name":"TOMBESI PAOLO","source":"filing","n_filings":4,"first_seen":"2020-03-26","last_seen":"2022-07-29"}],"transactions":[{"id":6824901,"accession":"0001209191-22-043510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043510","line_url":"/filing/0001209191-22-043510#line-1","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001707648","owner_name":"TOMBESI PAOLO","owner_display_name":"TOMBESI PAOLO","owner_url":"/insider/0001707648","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":74.94,"price_display":"74.94","price_state":"stated","total_value":88654.02,"total_display":"88,654.02","total_whole":"88,654","shares_owned_after":28700.0,"shares_owned_after_display":"28,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":4122444,"accession":"0000899243-21-005042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005042","line_url":"/filing/0000899243-21-005042#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001707648","owner_name":"TOMBESI PAOLO","owner_display_name":"TOMBESI PAOLO","owner_url":"/insider/0001707648","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1021.0,"shares_display":"1,021","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":11445.41,"total_display":"11,445.41","total_whole":"11,445","shares_owned_after":53465.0,"shares_owned_after_display":"53,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":2593047,"accession":"0000899243-20-017902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017902","line_url":"/filing/0000899243-20-017902#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001707648","owner_name":"TOMBESI PAOLO","owner_display_name":"TOMBESI PAOLO","owner_url":"/insider/0001707648","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1805.0,"shares_display":"1,805","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":29150.75,"total_display":"29,150.75","total_whole":"29,151","shares_owned_after":21942.0,"shares_owned_after_display":"21,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":2057509,"accession":"0000899243-20-009607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009607","line_url":"/filing/0000899243-20-009607#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001707648","owner_name":"TOMBESI PAOLO","owner_display_name":"TOMBESI PAOLO","owner_url":"/insider/0001707648","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1243.0,"shares_display":"1,243","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":18993.04,"total_display":"18,993.04","total_whole":"18,993","shares_owned_after":15437.0,"shares_owned_after_display":"15,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Officer (EVP & Chief Financial Officer)","n_filings":1,"first_seen":"2022-07-29","last_seen":"2022-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-03-26","last_seen":"2021-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001707648","retrieved_at":"2026-08-22T14:49:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}